Results 61 to 70 of about 17,715 (228)

Shear‐Responsive Red Blood Cell Carriers for Targeted Drug Delivery to Constricted Arteries

Small, EarlyView.
Red blood cells are harnessed as mechanoresponsive carriers that exploit the elevated shear stress of stenotic arteries to transiently open membrane pores and release encapsulated therapeutics selectively at sites of arterial narrowing. By coupling vascular hemodynamics with RBC membrane mechanics, a hemodynamically activated platform for localized ...
Danielle Nemcovsky Amar, Rukiye Tuna, Tirosh Mekler, Merav Belenkovich, Dmitry Korneyev, Yevgeniy Kreinin, Anat Glozman, Josué Sznitman, Donald E. Ingber, Zixiang Leonardo Liu, Netanel Korin   +10 more
wiley   +1 more source

The Use of a Left Ventricular Assist Device (LVAD) as a Modern Treatment Option for End-Stage Chronic Heart Failure: Clinical Characteristics, Complications, and Short-Term Outcomes

Juvenis Scientia
Introduction. Chronic heart failure (CHF) is one of the leading causes of death worldwide. Although guideline-directed pharmacotherapy can alleviate symptoms, it cannot restore the heart’s pump function.
Timofeev, E. V., Olifirenko, I. S., Zaripov, B. I., Platonova, N. A., Suvorova, A. I.   +4 more
doaj   +1 more source

Ischaemic Optic Neuropathy After Cardiac Surgery: A Systematic Review and Meta‐Analysis of Incidence and Risk Factors

ANZ Journal of Surgery, EarlyView.
Across 11 observational studies comprising 6 471 577 patients, the pooled incidence of ischaemic optic neuropathy after cardiac surgery was approximately 1.5 cases per 10 000 procedures. Coronary artery disease, peripheral vascular disease and anaemia were associated with increased odds of ION, although these findings should be interpreted in the ...
Daud Mutahar, Ammar Zaka, Amitouj S. Sidhu, Shahi Goswami, Aditi Singh, Jordan Ng, Brandon Stretton, Joshua G. Kovoor, Aashray K. Gupta, Stephen Bacchi, Weng Onn Chan, Celia Chen   +11 more
wiley   +1 more source

Analyzed LVAD waveform parameters.

, 2020
LVAD pump flow features analyzed to characterize patients’ response to exercise. For description of symbols please refer to the text.
Libera Fresiello (4268050), Heinrich Schima (8043344), Christiane Marko (8595759), Christoph Gross (8595750), Dominik Wiedemann (388586), Francesco Moscato (8413617), Martin Maw (8595762), Thomas Schlöglhofer (8595753), Kamen Dimitrov (8595756), Daniel Zimpfer (7900883), Bart Meyns (4268044)   +10 more
core   +1 more source

Geometry‐Related Technical Complications After LVAD Implantation: Impact on Device Dysfunction and Clinical Outcomes

Artificial Organs, EarlyView.
Preventable geometric failure modes, such as outflow graft kinking and inflow malposition, frequently cause HeartMate 3 dysfunction. This study identifies these complications as key drivers of device‐related morbidity, highlighting the importance of optimized surgical positioning to ensure long‐term device performance and improved clinical outcomes ...
Ali Saad Merzah, Ezin Deniz, Sara Knigge, Jasmin Hanke, Alina Zubarevich, Mohamad Dia, Chaikovska Sofia, Todurov Borys, Saeed Torabi, Bastian Schmack, Alexander Weymann, Zurab Darbaidze, Josephina Haunschild, Christian D. Etz, Max Biewer, Arjang Ruhparwar, Jan D. Schmitto, Günes Dogan   +17 more
wiley   +1 more source

Recent Developments in Ventricular Assist Device Therapy

Reviews in Cardiovascular Medicine
The evolution of left ventricular assist devices (LVADs) from large, pulsatile systems to compact, continuous-flow pumps has significantly improved implantation outcomes and patient mobility. Minimally invasive surgical techniques have emerged that offer
Angel Moctezuma-Ramirez, Haseeb Mohammed, Austin Hughes, Abdelmotagaly Elgalad   +3 more
doaj   +1 more source

Efficacy of Antimicrobial Silver‐Plated Dressings Compared to Usual Care in Preventing Left Ventricular Assist Device Driveline Infections

Artificial Organs, EarlyView.
Integrating silver‐plated wound dressings into DLES care presents a safe and effective strategy for DLI prevention. Key findings include a 100% infection‐free rate in the Silverlon group, no NPWT and hospital readmission in the Silverlon group, and no severe DESTINE stages (3, 4) in the Silverlon group.
Barbara Veiter, Martina Socha, Christiane Marko, Nesibe Seyda Colak, Alexandra Kuhn, Hebe Al Asadi, Julia Riebandt, Roxana Moayedifar, Daniel Zimpfer, Thomas Schlöglhofer   +9 more
wiley   +1 more source

Mitral regurgitation changes after LVAD implantation: a numerical study.

, 2014
Aim: Although the left ventricular (LV) unloading due to LVAD, in some patients (PTs) with severe mitral regurgitation (MR) and severe LV and left atrium dilation,a suboptimal results of LVAD implantation, characterized by persistent relevant MR ...
Frigerio, Maria, Ferrari, Gianfranco, Di Molfetta, Arianna, Verde, Alessandro, Zielinski, Krzysztof, Trivella, Maria Giovanna, Palko, Krzysztof Jakub, Fresiello, Libera   +7 more
core   +1 more source

Patient characteristics HTX and LVAD patients.

, 2022
Patient characteristics HTX and LVAD patients.
Sebastian Roth (13173045), Ragnar Huhn (777631), Markus W. Hollmann (9727530), René M’Pembele (13173042), Michiel Morshuis (3279255), Thomas Bitter (4389781), Giovanna Lurati Buse (13961330), Henrik Fox (8385882)   +7 more
core   +1 more source

Impact of centrifugal-flow left ventricular assist device implantation on the disease course, functional class, and quality of life in patients with end-stage heart failure with reduced ejection fraction. A 6-month follow-up experience

Российский кардиологический журнал
Aim. To study mortality, postoperative complications, clinical course, and quality of life of patients with heart failure (HF) within 6 months after left ventricular assist device (LVAD) implantation.Material and methods.
Zh. A. Shakhramanova, O Yu. Narusov, V. A. Amanatova, Yu. F. Osmolovskaya, K. G. Ganaev, A. A. Shiryaev, R. S. Akchurin, I. A. Merkulova, D. V. Pevsner, M. A. Saidova, S. N. Tereschenko   +10 more
doaj   +1 more source